Enzo Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Enzo Biochem
ENZ Stock  USD 0.98  0.01  1.03%   
Enzo Biochem financial statements provide useful quarterly and yearly information to potential Enzo Biochem investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Enzo Biochem financial statements helps investors assess Enzo Biochem's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Enzo Biochem's valuation are summarized below:
Gross Profit
11.6 M
Profit Margin
(0.82)
Market Capitalization
50.9 M
Enterprise Value Revenue
0.0651
Revenue
31.9 M
We have found one hundred twenty available fundamental signals for Enzo Biochem, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Enzo Biochem prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 49.6 M in 2024. Enterprise Value is likely to drop to about 7.8 M in 2024

Enzo Biochem Total Revenue

63.05 Million

Check Enzo Biochem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enzo Biochem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 187.2 K or Total Revenue of 63.1 M, as well as many indicators such as Price To Sales Ratio of 1.73, Dividend Yield of 2.0E-4 or PTB Ratio of 0.98. Enzo financial statements analysis is a perfect complement when working with Enzo Biochem Valuation or Volatility modules.
  
Check out the analysis of Enzo Biochem Correlation against competitors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Enzo Biochem Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets100.6 M85.8 M93 M
Slightly volatile
Short and Long Term Debt Total3.3 M3.5 M10.9 M
Pretty Stable
Other Current Liabilities23.6 M22.5 M11.5 M
Slightly volatile
Total Current Liabilities15.1 M24.8 M22.1 M
Slightly volatile
Total Stockholder Equity74.8 M56.1 M61.6 M
Slightly volatile
Property Plant And Equipment Net12.5 M15.2 M14.7 M
Slightly volatile
Cash42.5 M52.4 M41.7 M
Slightly volatile
Non Current Assets Total14.9 M15.7 M25.7 M
Pretty Stable
Non Currrent Assets Other503.5 K530 K1.8 M
Slightly volatile
Cash And Short Term Investments46.6 M52.4 M43.9 M
Slightly volatile
Net Receivables3.8 M4 M9.9 M
Slightly volatile
Common Stock Shares Outstanding37.4 M50.9 M43.5 M
Slightly volatile
Liabilities And Stockholders Equity100.6 M85.8 M93 M
Slightly volatile
Non Current Liabilities Total7.8 M4.9 M9.1 M
Pretty Stable
Inventory5.6 M6.8 M8 M
Slightly volatile
Other Current Assets7.2 M6.8 M3.6 M
Slightly volatile
Other Stockholder Equity220 M348.1 M300.7 M
Slightly volatile
Total Liabilities18.8 M29.7 M30.9 M
Pretty Stable
Property Plant And Equipment Gross33.6 M32 M20.5 M
Slightly volatile
Total Current Assets68.6 M70 M66.2 M
Slightly volatile
Intangible Assets6.7 M6.7 M5.1 M
Pretty Stable
Accounts Payable1.3 M1.4 M6.6 M
Slightly volatile
Short Term Debt871.1 K917 K2.7 M
Very volatile
Common Stock Total Equity422.6 K560 K446.8 K
Slightly volatile
Common Stock433.3 K521 K445.7 K
Slightly volatile
Other Liabilities4.3 K4.5 K597.7 K
Slightly volatile
Other Assets6.3 M6 M2.3 M
Slightly volatile
Good Will8.5 M6.7 M7.5 M
Pretty Stable
Property Plant Equipment10.2 M19.2 M12.4 M
Slightly volatile
Long Term Debt179.6 K189 K1.3 M
Slightly volatile
Net Tangible Assets58.6 M90.2 M54.5 M
Slightly volatile
Capital Surpluse359.7 M396.1 M332.3 M
Slightly volatile
Non Current Liabilities Other15.4 M14.7 M5.4 M
Slightly volatile
Short and Long Term Debt72.2 K76 K2 M
Slightly volatile
Long Term Debt Total293.9 K309.4 K1.5 M
Pretty Stable
Capital Lease Obligations3.1 M3.2 M4.8 M
Slightly volatile
Cash And Equivalents41.7 M74.1 M58.2 M
Slightly volatile
Net Invested Capital60 M56.4 M79.5 M
Slightly volatile
Net Working Capital41.4 M45.2 M58.8 M
Slightly volatile
Capital Stock537.3 K521 K484 K
Slightly volatile

Enzo Biochem Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.5 M1.3 M3 M
Slightly volatile
Total Revenue63.1 M31.9 M81.4 M
Pretty Stable
Gross Profit13.9 M14.6 M33.2 M
Slightly volatile
Other Operating Expenses70.6 M44.3 M91.3 M
Very volatile
Cost Of Revenue31.5 M17.3 M47.1 M
Pretty Stable
Total Operating Expenses39 M27 M44.2 M
Very volatile
Research Development4.2 M2.6 M3.6 M
Very volatile
Selling General Administrative39.7 M24.4 M40.7 M
Very volatile
Selling And Marketing Expenses2.8 M2.6 M742 K
Slightly volatile
Interest Income3.7 M3.5 M1.3 M
Slightly volatile
Reconciled Depreciation2.2 M1.3 M3.1 M
Slightly volatile
Extraordinary Items54.7 M52.1 M11.3 M
Slightly volatile
Discontinued Operations54.7 M52.1 M11.8 M
Slightly volatile

Enzo Biochem Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow87.5 M83.4 M41.7 M
Slightly volatile
Depreciation1.2 M1.3 M2.9 M
Slightly volatile
Capital Expenditures517.8 K545 K2.7 M
Pretty Stable
End Period Cash Flow41.6 M52.4 M40.4 M
Slightly volatile
Stock Based Compensation2.1 M2.3 M1.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.731.81872.9021
Slightly volatile
Dividend Yield2.0E-42.0E-43.0E-4
Slightly volatile
PTB Ratio0.981.03422.7051
Slightly volatile
Days Sales Outstanding43.3445.620747.8109
Slightly volatile
Book Value Per Share2.21.10241.4325
Slightly volatile
Stock Based Compensation To Revenue0.07560.0720.03
Slightly volatile
Capex To Depreciation0.410.42852.7054
Slightly volatile
PB Ratio0.981.03422.7051
Slightly volatile
Inventory Turnover4.662.52855.7764
Slightly volatile
Days Of Inventory On Hand85.6914476.4405
Slightly volatile
Payables Turnover6.3412.55457.5864
Slightly volatile
Sales General And Administrative To Revenue0.440.76330.5187
Slightly volatile
Research And Ddevelopement To Revenue0.09990.08280.054
Slightly volatile
Capex To Revenue0.01620.01710.0771
Slightly volatile
Cash Per Share1.451.02891.1017
Very volatile
Payout Ratio0.01120.01260.0137
Slightly volatile
Days Payables Outstanding27.6229.073251.3125
Slightly volatile
Intangibles To Total Assets0.130.070.1269
Slightly volatile
Current Ratio2.682.82454.5937
Slightly volatile
Tangible Book Value Per Share1.261.10241.1674
Slightly volatile
Receivables Turnover4.498.00088.7298
Very volatile
Graham Number2.783.56473.5364
Very volatile
Shareholders Equity Per Share2.21.10241.4325
Slightly volatile
Debt To Equity0.00450.00470.1947
Slightly volatile
Capex Per Share0.01020.01070.0851
Slightly volatile
Revenue Per Share0.60.62681.7644
Slightly volatile
Interest Debt Per Share0.00860.00910.4052
Slightly volatile
Debt To Assets0.00290.00310.0803
Slightly volatile
Operating Cycle189190128
Pretty Stable
Price Book Value Ratio0.981.03422.7051
Slightly volatile
Days Of Payables Outstanding27.6229.073251.3125
Slightly volatile
Dividend Payout Ratio0.01120.01260.0137
Slightly volatile
Ebt Per Ebit0.960.911.0403
Slightly volatile
Company Equity Multiplier3.041.52841.731
Very volatile
Long Term Debt To Capitalization0.00320.00340.0699
Slightly volatile
Total Debt To Capitalization0.00450.00470.1002
Slightly volatile
Debt Equity Ratio0.00450.00470.1947
Slightly volatile
Quick Ratio2.422.5494.2031
Slightly volatile
Cash Ratio2.012.11223.4532
Slightly volatile
Cash Conversion Cycle13116178.9946
Pretty Stable
Days Of Inventory Outstanding85.6914476.4405
Slightly volatile
Days Of Sales Outstanding43.3445.620747.8109
Slightly volatile
Price To Book Ratio0.981.03422.7051
Slightly volatile
Fixed Asset Turnover1.992.09877.2658
Slightly volatile
Debt Ratio0.00290.00310.0803
Slightly volatile
Price Sales Ratio1.731.81872.9021
Slightly volatile
Asset Turnover0.50.3720.9174
Slightly volatile
Gross Profit Margin0.610.45860.4504
Pretty Stable
Price Fair Value0.981.03422.7051
Slightly volatile

Enzo Biochem Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap49.6 M52.2 M131.1 M
Slightly volatile
Enterprise Value7.8 M8.2 M80.9 M
Slightly volatile

Enzo Fundamental Market Drivers

Cash And Short Term Investments52.4 M

Enzo Upcoming Events

18th of March 2024
Upcoming Quarterly Report
View
31st of January 2024
Next Fiscal Quarter End
View

About Enzo Biochem Financial Statements

Enzo Biochem investors use historical fundamental indicators, such as Enzo Biochem's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Enzo Biochem. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue5.9 M3.7 M
Total Revenue31.9 M63.1 M
Cost Of Revenue17.3 M31.5 M
Stock Based Compensation To Revenue 0.07  0.08 
Sales General And Administrative To Revenue 0.76  0.44 
Research And Ddevelopement To Revenue 0.08  0.10 
Capex To Revenue 0.02  0.02 
Revenue Per Share 0.63  0.60 
Ebit Per Revenue(0.31)(0.29)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY